The Efficacy and Safety of Qishenyiqi Dripping Pill in Patients With Coronary Microvascular Disease
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 75
Healthy Volunteers: f
View:
• Repeated chest pain attacks with typical exertional angina pectoris or resting angina pectoris attacks;
• Coronary normal or stenosis \< 20%;
• Ischemic depression in ST segment during resting or exercise;
• Blood flow reserve (CFR) of the anterior descending coronary artery \< 2.0;
• Subjects or their guardians agreed to participate in this study.
Locations
Other Locations
China
Jinan Central Hospital Affiliated to Shandong First Medical University
RECRUITING
Jinan
Qianfoshan Hospital, Shandong University
ACTIVE_NOT_RECRUITING
Jinan
Qilu Hospital of Shandong University
RECRUITING
Jinan
Contact Information
Primary
Panpan Hao, Dr.
panda.how@sdu.edu.cn
8618560086593
Time Frame
Start Date: 2023-11-08
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 162
Treatments
Experimental: Qishenyiqi Dripping Pill
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: Qilu Hospital of Shandong University